SEARCH

SEARCH BY CITATION

References

  • 1
    Roccella EJ, Ward G. The national high blood pressure education program: a description of its utility as a generic program model. Health Educ Q. 1984;11:225242.
  • 2
    Jones DW, Hale JE. The national high blood pressure education program: thirty years and counting. Hypertension. 2002;39:941942.
  • 3
    Centers for Disease Control and Prevention (CDC). Ten greatest public health achievements-United States, 1900–1999. MMWR. 1999;48:241243.
  • 4
    Vasan RS, Beiser A, Seshadri S, et al.Residual lifetime risk for developing hypertension in middle-aged women and men. The Framingham Heart Study. JAMA. 2002;287:10031010.
  • 5
    Centers for Disease Control and Prevention. Ambulatory care use and physician visits. http://www.cdc.gov/nchs/fastats/docvisit.htm. Accessed November 1, 2012.
  • 6
    Centers for Disease Control and Prevention. Leading causes of death. http://www.cdc.gov/nchs/fastats/lcod.htm. Accessed November 1, 2012.
  • 7
    Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment and control of hypertension, 1988–2008. JAMA. 2010;303:20432050.
  • 8
    National Heart Lung and Blood Institute. NHLBI Fact Book. http://www.nhlbi.nih.gov/about/factbook. Accessed November 1, 2012.
  • 9
    Moses J, Cross L. Presidential Courage . New York, NY: Norton; 1980.
  • 10
    Bruenn HG. Clinical notes on the illness and death of President Franklin D. Roosevelt. Ann Intern Med. 1970;72:579591.
  • 11
    Kempner W. Treatment of kidney disease and hypertensive vascular disease with rice diet. NC Med J. 1944;5:125127.
  • 12
    Smithwick R. The effects of sympathectomy upon the mortality and survival rates of patients with hypertensive cardiovascular disease. In: Bell ET, ed. Hypertension. Minneapolis, MN: Minnesota Press; 1951:429457.
  • 13
    White PD. Heart Disease, 2nd edn. New York: Macmillan; 1937:326.
  • 14
    Friedberg CK. Diseases of the Heart. Philadelphia, PA: Saunders; 1949.
  • 15
    Moser M. Misconceptions and Heroics—The Story of the Treatment of Hypertension from the 1930s, 2nd ed. Darien, CT: LeJacq Communications Inc.; 2002.
  • 16
    Page IH, Taylor RD. Pyrogens in the treatment of malignant hypertension. Mod Concepts Cardiovasc Dis. 1949;18:5152.
  • 17
    Freis ED, Wilkins RW. Effect of pentaquine in patients with hypertension. Proc Soc Exp Biol Med. 1947;64:731736.
  • 18
    Kannel WB, Schwartz MJ, McNamara PM. Blood pressure and risk of coronary heart disease: the Framingham study. Dis Chest. 1969;56:4352.
  • 19
    Haimovici H, Moser M, Krakower H. The effect of oral 688A on the blood pressure and pulse rate in normotensive and hypertensive subjects. Proc Soc Exper Biol Med. 1951;77:477.
  • 20
    Moser M, Reppert E, Prandoni AC, Mattingly TW. Autonomic blocking agents in cardiovascular disease. Postgrad Med. 1955;17:362.
  • 21
    Veterans Administration Cooperative Study Group on Antihypertensive Agents: effect of treatment on morbidity in hypertension: Results in patients with diastolic blood pressure averaging 115 through 129 mm Hg. JAMA. 1967;202:10281034.
  • 22
    Moser M. Evolution of the treatment of hypertension from the 1940s to JNC V. Am J Hypertens. 1997;10:2S8S.
  • 23
    Moser M, Guyther JR, Finnerty F, et al.Report of the Joint National Committee on detection, evaluation and treatment of high blood pressure (JNC I). JAMA. 1977;237:255261.
  • 24
    Moser M. From JNC I to JNC 7 – what have we learned?Prog Cardiovasc Dis. 2006;48:303315.
  • 25
    Perry MH, Roccella EJ. Conference report on stroke mortality in the southeastern United States. Hypertension. 1998;31:12061215.
  • 26
    Burt VL, Cutler JA, Higgens M, et al.Trends in prevalence, awareness, treatment and control of hypertension in the adult US population: data from the Health Examination Surveys, 1960 to 1991. Hypertension. 1995;26:6069.
  • 27
    He J, Muntner P, Chen J, et al.Factors associated with hypertension control in the general population of the United States. Arch Intern Med. 2002;162:10511058.
  • 28
    Foote A, Erfurt JC. Controlling hypertension: a cost effective model. Prev Med. 1977;6:319343.
  • 29
    Horan MJ. The national high blood pressure education program: measuring progress and assessing its impact. Health Psychol. 1988;7(suppl):297303.
  • 30
    Moser M, Franklin SS. Hypertension management: results of a new national survey for the hypertension education foundation: Harris interactive. J Clin Hypertens. 2007;9:316323.
  • 31
    Cutler JA, Sorlie PD, Wolz M, et al.Trends in the prevalence, awareness, treatment and control of hypertension in the US adults between 1988–1994 and 1999–2004. Hypertension. 2008;52:801827.
  • 32
    Whelton PK, He J, Appel LJ, et al.Primary prevention of hypertension: clinical and public health advisory from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Coordinating Committee. JAMA. 2002;288:18821888.